The leukemic clone of CML originates from a hematopoietic stem cell (HSC) by gaining the chromosomal translocation t(9;22)(q34;q11) containing the BCR-ABL1 fusion gene. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.